INS and type 2 diabetes mellitus: The choice between GLP‐1RAs and basal insulin as the first injectable therapy in T2DM is not only a matter of safety but also of efficacy, as some once‐weekly GLP‐1RAs have demonstrated significant HbA1c reductions when compared to basal insulins.28, 29